May 24, 2026
Headlines

Pharma Industry

Divi's Laboratories Announces 1500% Dividend Following Strong Q4 FY26 Financial Performance

Divi’s Laboratories Announces 1500% Dividend Following Strong Q4 FY26 Financial Performance

Business News Desk03 mins mins

Divi’s Laboratories, a global leader in active pharmaceutical ingredients (APIs), reported a robust financial performance for the fourth quarter of fiscal year 2025-26, highlighted by a 13.4% year-on-year increase in profit after tax (PAT) to Rs 751 crore. Alongside these earnings, the company’s board recommended a significant dividend of Rs 30 per share—representing a 1500%…

Read More
Alembic Pharmaceuticals Posts 29% Profit Surge, Enters US Branded Market

Alembic Pharmaceuticals Posts 29% Profit Surge, Enters US Branded Market

Business News Desk02 mins mins

Alembic Pharmaceuticals Ltd announced a 29 percent year-on-year increase in consolidated net profit, reaching Rs 202.7 crore for the fourth quarter ended March 31, 2026. The Vadodara-based pharmaceutical company, which released its results on Friday, also declared a 600 percent dividend of Rs 12 per share to reward shareholders following the robust financial performance. Context…

Read More